Fibrinolytic therapy innovation creating infrastructure — non-specific plasminogen activators enabling thrombus dissolution in acute cardiovascular and cerebrovascular events, establishing fibrinolytic therapy as essential emergency vascular infrastructure, with the Non-Specific Plasminogen Activator Market experiencing expansion driven by acute thrombotic disease prevalence, reperfusion...